Q: OTEX reported a 0.1% constant currency organic growth rate for F19 implying revenues were basically flat because of a slowdown in Q4 license sales ex-acquisitions. Slowdowns in license sales should impact customer support revenues which is an important recurring source. Is this strictly a grow-by-acquisition game that can produce too many negative surprises and nasty stock corrections to bother with? If so, which TSX tech stocks would be a higher quality choice? Appreciate your service!
Q: Cyberark released a good quarter this morning but the stock is down huge (9%). Is there some news that I'm missing in the earnings that point to slower growth? Would you hold?
Q: Is 5i considering a closer look at Sangoma Technologies for their growth portfolio and/or research coverage? The Company's management is consistently beating analyst estimates and the market cap is now over $100 million with a lot of value given the 4 analyst estimates going forward.
Q: I would appreciate your advice upon IPGP. I have held this stock for a number of years and still show a small profit of 18%. However it has declined severely in the past year and is very volatile. Would you continue to hold? If not, would you suggest a couple of possible replacements.
Thanks for your help.
Q: Would you consider this is a good growth stock to add to a portfolio after the latest earnings? Revenue growth looks to be increasing faster, and guidance was increased. They have a good track record with beating earnings too. Can you add any insights on their management team?
I’m looking for my next TEAM, AYX, TTD, RPD all of which I own thanks to you! Any other tech suggestions in the US?
Q: Hello. In monitoring my equity investments, I note that SHOP is now 8.3% of my total stock portfoliio while CSU has reached 7.5% of that same total. My question is whether it is too risky to let these run -- or trim them back now. Thanks!